These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 649987)

  • 1. Inactivation of penicillin G during experimental infection with Bacteroides fragilis.
    O'Keefe JP; Tally FP; Barza M; Gorbach SL
    J Infect Dis; 1978 Apr; 137(4):437-42. PubMed ID: 649987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP; Tally FP; Barza M; Gorbach SL
    Rev Infect Dis; 1979; 1(1):106-12. PubMed ID: 318211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbenicillin for treatment of Bacteroides fragilis infections: why not penicillin G?
    Maki DG; Kurzynski TA; Agger WA
    J Infect Dis; 1978 Dec; 138(6):859-64. PubMed ID: 253006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of an experimental Bacteroides fragilis infection in mice.
    Walker CB; Nitzan D; Wilkins TD
    Antimicrob Agents Chemother; 1977 Mar; 11(3):435-40. PubMed ID: 855998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillin failure in the treatment of Bacteroides fragilis lung abscess. Experimental study in rabbits.
    Thadepalli H; Kannangara DW; Bach VT
    Chemotherapy; 1983; 29(4):289-93. PubMed ID: 6872619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of latamoxef (moxalactam) against both Bacteroides fragilis and Escherichia coli in an intraperitoneal abscess model.
    Harris RW; Moore WL; Arensman JB; Rissing JP
    J Antimicrob Chemother; 1984 Nov; 14(5):499-508. PubMed ID: 6392279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-lactamases in bacteroides.
    Nord CE; Olsson B; Dornbusch K
    Scand J Infect Dis Suppl; 1978; (13):27-32. PubMed ID: 28561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
    Hackman AS; Wilkins TD
    Antimicrob Agents Chemother; 1975 May; 7(5):698-703. PubMed ID: 1041218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin resistant Bacteroides melaninogenicus infection of the mandible.
    Bahn SL; Segal AG
    J Conn State Dent Assoc; 1982 Aug; 56(3):105-6. PubMed ID: 6130105
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic management of anaerobic infections.
    Brook I
    Hosp Pract (Off Ed); 1982 Aug; 17(8):203, 206-7, 210-11 passim. PubMed ID: 6807815
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in mice.
    Hackman AS; Wilkins TD
    Arch Oral Biol; 1976; 21(6):385-9. PubMed ID: 8031
    [No Abstract]   [Full Text] [Related]  

  • 13. Penetration of clindamycin into experimental infections with Bacteroides fragilis.
    Simon GL; Richmond DM; Tally FP; Barza M; Gorbach SL
    J Antimicrob Chemother; 1981 Jul; 8(1):59-64. PubMed ID: 7251540
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of clindamycin into experimental Staphylococcus aureus infections.
    Simon GL; Miller HG; Camas JM; Geelhoed GW
    Surg Gynecol Obstet; 1984 Apr; 158(4):349-53. PubMed ID: 6710298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647).
    Thadepalli H; Chuah SK; Qazi S; Thadepalli F; Gollapudi SV
    Chemotherapy; 2001; 47(1):43-9. PubMed ID: 11125232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to Bacteroides fragilis in experimentally infected rabbits.
    Schwan A; Danielsson D
    Scand J Infect Dis; 1983; 15(1):25-32. PubMed ID: 6221401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic therapy of endometritis following cesarean section. Treatment successes and failures.
    Gibbs RS; Jones PM; Wilder CJ
    Obstet Gynecol; 1978 Jul; 52(1):31-7. PubMed ID: 683627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaerobic meningitis in an infant associated with pilonidal cyst abscess.
    Brook I
    Clin Neurol Neurosurg; 1985; 87(2):131-2. PubMed ID: 4028588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.